Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1951 Feb 28;93(3):285–296. doi: 10.1084/jem.93.3.285

THE PATHOGENESIS OF INFECTION WITH A VIRULENT (CG 179) AND AN AVIRULENT (B) STRAIN OF NEWCASTLE DISEASE VIRUS IN THE CHICKEN

II. DEVELOPMENT OF ANTIBODY

David T Karzon 1, Frederik B Bang 1
PMCID: PMC2136085  PMID: 14824401

Abstract

Circulating antibody appeared in the convalescing NDV-infected chicken concomitantly with the disappearance of virus from the tissues. The antigenic response to the CG 179 and B strains was demonstrated to be approximately equal. The neutralization test in the embryo and the hemagglutination inhibition technique yielded parallel results in the measurement of antibody early in convalescence, but late in convalescence the hemagglutination inhibition titers were relatively lower. This disparity indicates the possible duality of the antibodies. There was a wide ratio between the neutralizing antibody titers found in the brain and in the serum after an asymptomatic infection with NDV. The antibody level in the brain appeared to be related to the extent of virus growth and damage in the central nervous system. It appeared likely that a major factor in determining the virulence of the CG 179 strain was the more rapid attainment in the central nervous system of high virus concentration which outstripped the defense mechanisms of the host.

Full Text

The Full Text of this article is available as a PDF (600.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BANG F. B., FOARD M., KARZON D. T. The determination and significance of substances neutralizing Newcastle virus in human serum. Bull Johns Hopkins Hosp. 1950 Aug;87(21):130–143. [PubMed] [Google Scholar]
  2. BANG F. B., LIBERT R. Agglutination of red cells altered by the action of Newcastle disease virus; the effect of chicken sera from infected birds on sensitized cells. Bull Johns Hopkins Hosp. 1949 Dec;85(6):416–430. [PubMed] [Google Scholar]
  3. Fox J. P. IMMUNITY TO YELLOW FEVER ENCEPHALITIS OF MONKEYS AND MICE IMMUNIZED BY NEURAL AND EXTRANEURAL ROUTES. J Exp Med. 1943 Jun 1;77(6):487–506. doi: 10.1084/jem.77.6.487. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Freund J. ACCUMULATION OF ANTIBODIES IN THE CENTRAL NERVOUS SYSTEM. J Exp Med. 1930 May 31;51(6):889–902. doi: 10.1084/jem.51.6.889. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Friedewald W. F. QUALITATIVE DIFFERENCES IN THE ANTIGENIC COMPOSITION OF INFLUENZA A VIRUS STRAINS. J Exp Med. 1944 Jun 1;79(6):633–647. doi: 10.1084/jem.79.6.633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hirst G. K. THE QUANTITATIVE DETERMINATION OF INFLUENZA VIRUS AND ANTIBODIES BY MEANS OF RED CELL AGGLUTINATION. J Exp Med. 1942 Jan 1;75(1):49–64. doi: 10.1084/jem.75.1.49. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Morgan I. M., Schlesinger R. W., Olitsky P. K. INDUCED RESISTANCE OF THE CENTRAL NERVOUS SYSTEM TO EXPERIMENTAL INFECTION WITH EQUINE ENCEPHALOMYELITIS VIRUS : I. NEUTRALIZING ANTIBODY IN THE CENTRAL NERVOUS SYSTEM IN RELATION TO CEREBRAL RESISTANCE. J Exp Med. 1942 Oct 1;76(4):357–369. doi: 10.1084/jem.76.4.357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. SCHLESINGER R. W. The mechanism of active cerebral immunity to equine encephalomyelitis virus; the local antigenic booster effect of the challenge inoculum. J Exp Med. 1949 May;89(5):507–527. doi: 10.1084/jem.89.5.507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. WALKER D. L., HORSFALL F. L., Jr Lack of identity in neutralizing and hemagglutination-inhibiting antibodies against influenza viruses. J Exp Med. 1950 Jan 1;91(1):65–86. doi: 10.1084/jem.91.1.65. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES